Zoledronic acid versus ibandronate comparative evaluation in breast cancer patients with bone metastases: the NCRI zice trial
Zoledronic acid versus ibandronate comparative evaluation in breast cancer patients with bone metastases: the NCRI zice trial
S67-S67
Barrett-Lee, P.J.
93eae7ba-8dcf-412d-bee1-a09634cc8b69
Murray, N.
07091b97-fea7-483e-953d-64bc89b3ee96
March 2006
Barrett-Lee, P.J.
93eae7ba-8dcf-412d-bee1-a09634cc8b69
Murray, N.
07091b97-fea7-483e-953d-64bc89b3ee96
Barrett-Lee, P.J. and Murray, N.
(2006)
Zoledronic acid versus ibandronate comparative evaluation in breast cancer patients with bone metastases: the NCRI zice trial.
Bone, 38 (3 Supplement 1), .
(doi:10.1016/j.bone.2006.01.008).
This record has no associated files available for download.
More information
Published date: March 2006
Identifiers
Local EPrints ID: 62683
URI: http://eprints.soton.ac.uk/id/eprint/62683
ISSN: 8756-3282
PURE UUID: 7181640e-d88f-48c3-a56b-a1413f7c0ffb
Catalogue record
Date deposited: 15 Jan 2009
Last modified: 15 Mar 2024 11:32
Export record
Altmetrics
Contributors
Author:
P.J. Barrett-Lee
Author:
N. Murray
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics